Smart multifunctional nanoagents for in situ monitoring of small molecules with a switchable affinity towards biomedical targets

Abstract

The great diversity of nanomaterials provides ample opportunities for constructing effective agents for biomedical applications ranging from biosensing to drug delivery. Multifunctional nanoagents that combine several features in a single particle are of special interest due to capabilities that substantially exceed those of molecular drugs. An ideal theranostic agent should simultaneously be an advanced biosensor to identify a disease and report the diagnosis and a biomedical actuator to treat the disease. While many approaches were developed to load a nanoparticle with various drugs for actuation of the diseased cells (e.g., to kill them), the nanoparticle-based approaches for the localized biosensing with real-time reporting of the marker concentration severely lag behind. Here, we show a smart in situ nanoparticle-based biosensor/actuator system that dynamically and reversibly changes its structural and optical properties in response to a small molecule marker to allow real-time monitoring of the marker concentration and adjustment of the system ability to bind its biomedical target. Using the synergistic combination of signal readout based on the localized surface plasmon resonance and an original method of fabrication of smart ON/OFF-switchable nanoagents, we demonstrate reversible responsiveness of the system to a model small molecule marker (antibiotic chloramphenicol) in a wide concentration range. The proposed approach can be used for the development of advanced multifunctional nanoagents for theranostic applications.

Advanced Smart Nanomaterials with Integrated Logic-Gating and Biocomputing: Dawn of Theranostic Nanorobots

“…Finally, the Nikitin group reported assembling AuNPs on the surface of polystyrene-coated magnetic microspheres which were used to shield the output receptor (biotin) in YES-gated biocomputing nanostructures, , whose general design (“biocomputing based on particles disassembly” concept) was discussed in the previous section. The core particles were modified with two conjugates of BSA with chloramphenicol and biotin (CAP-BSA and BIO-BSA, respectively), while shielding AuNPs were functionalized with anti-CAP antibodies.…”

A Straightforward Method for the Development of Positively Charged Gold Nanoparticle-Based Vectors for Effective siRNA Delivery

“…Gold nanoparticles (AuNPs) have become a popular choice for core nanoparticle scaffolds due to their ability to be easily detected and quantified, as well as because of their potential biocompatibility resulting from their chemical stability. These attributes have led to their extensive use in diagnostic and therapeutic areas of research [37][38][39][40][41][42]. In recent years, AuNPs have gained popularity as delivery vehicles for a variety of bioactive agents, including proteins and peptides [43], plasmid DNA [44,45], and antisense oligonucleotides [46,47].…”

PLGA Nanoparticles Decorated with Anti-HER2 Affibody for Targeted Delivery and Photoinduced Cell Death

“…The development of new, and the improvement of existing methods of diagnostics and therapy of oncological diseases is impossible without the involvement of new non-standard tools in biology and biomedicine [ 1 , 2 ]. Nanoparticles of various natures have a wide range of properties that are not inherent in bulk samples or small molecules, thus making it possible to solve the most pressing problems both in therapy and in the diagnosis of diseases [ 3 , 4 , 5 , 6 , 7 , 8 , 9 ].…”